Pimaric acid

Details

Top
Internal ID af2513c0-c3e4-4cfb-83b4-51405e496751
Taxonomy Lipids and lipid-like molecules > Prenol lipids > Diterpenoids
IUPAC Name (1R,4aR,4bS,7S,10aR)-7-ethenyl-1,4a,7-trimethyl-3,4,4b,5,6,9,10,10a-octahydro-2H-phenanthrene-1-carboxylic acid
SMILES (Canonical) CC1(CCC2C(=C1)CCC3C2(CCCC3(C)C(=O)O)C)C=C
SMILES (Isomeric) C[C@]1(CC[C@H]2C(=C1)CC[C@@H]3[C@@]2(CCC[C@@]3(C)C(=O)O)C)C=C
InChI InChI=1S/C20H30O2/c1-5-18(2)12-9-15-14(13-18)7-8-16-19(15,3)10-6-11-20(16,4)17(21)22/h5,13,15-16H,1,6-12H2,2-4H3,(H,21,22)/t15-,16+,18+,19+,20+/m0/s1
InChI Key MHVJRKBZMUDEEV-APQLOABGSA-N
Popularity 319 references in papers

Physical and Chemical Properties

Top
Molecular Formula C20H30O2
Molecular Weight 302.50 g/mol
Exact Mass 302.224580195 g/mol
Topological Polar Surface Area (TPSA) 37.30 Ų
XlogP 5.50
Atomic LogP (AlogP) 5.21
H-Bond Acceptor 1
H-Bond Donor 1
Rotatable Bonds 2

Synonyms

Top
Dextropimaric acid
127-27-5
d-Pimaric acid
Usic acid
PIMARIC ACID, D
(+)-Pimaric acid
Pimara-8(14),15-dien-19-oic acid
.alpha.-Pimaric acid
NSC2956
delta8(14)-Pimaric acid
There are more than 10 synonyms. If you wish to see them all click here.

2D Structure

Top
2D Structure of Pimaric acid

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9962 99.62%
Caco-2 + 0.8606 86.06%
Blood Brain Barrier + 0.7250 72.50%
Human oral bioavailability + 0.5143 51.43%
Subcellular localzation Mitochondria 0.4127 41.27%
OATP2B1 inhibitior - 0.8625 86.25%
OATP1B1 inhibitior + 0.8373 83.73%
OATP1B3 inhibitior - 0.4703 47.03%
MATE1 inhibitior - 0.9600 96.00%
OCT2 inhibitior + 0.6000 60.00%
BSEP inhibitior + 0.7840 78.40%
P-glycoprotein inhibitior - 0.8340 83.40%
P-glycoprotein substrate - 0.8784 87.84%
CYP3A4 substrate + 0.5658 56.58%
CYP2C9 substrate - 0.5859 58.59%
CYP2D6 substrate - 0.8733 87.33%
CYP3A4 inhibition - 0.8276 82.76%
CYP2C9 inhibition + 0.8949 89.49%
CYP2C19 inhibition + 0.7575 75.75%
CYP2D6 inhibition - 0.9231 92.31%
CYP1A2 inhibition - 0.7748 77.48%
CYP2C8 inhibition - 0.7309 73.09%
CYP inhibitory promiscuity - 0.8959 89.59%
UGT catelyzed - 0.0000 0.00%
Carcinogenicity (binary) - 0.8800 88.00%
Carcinogenicity (trinary) Non-required 0.5883 58.83%
Eye corrosion - 0.9683 96.83%
Eye irritation - 0.9036 90.36%
Skin irritation - 0.6521 65.21%
Skin corrosion - 0.9781 97.81%
Ames mutagenesis - 0.7800 78.00%
Human Ether-a-go-go-Related Gene inhibition - 0.4622 46.22%
Micronuclear - 0.9200 92.00%
Hepatotoxicity - 0.5348 53.48%
skin sensitisation + 0.7018 70.18%
Respiratory toxicity + 0.6444 64.44%
Reproductive toxicity + 0.5556 55.56%
Mitochondrial toxicity + 0.7500 75.00%
Nephrotoxicity - 0.6388 63.88%
Acute Oral Toxicity (c) III 0.7692 76.92%
Estrogen receptor binding + 0.5627 56.27%
Androgen receptor binding + 0.5861 58.61%
Thyroid receptor binding + 0.7158 71.58%
Glucocorticoid receptor binding + 0.8038 80.38%
Aromatase binding - 0.4893 48.93%
PPAR gamma - 0.5488 54.88%
Honey bee toxicity - 0.9105 91.05%
Biodegradation - 0.6250 62.50%
Crustacea aquatic toxicity - 0.6500 65.00%
Fish aquatic toxicity + 1.0000 100.00%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
CHEMBL3622 P33261 Cytochrome P450 2C19 7943.3 nM
Potency
via CMAUP
CHEMBL3397 P11712 Cytochrome P450 2C9 6309.6 nM
Potency
via CMAUP

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 92.14% 91.11%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 91.50% 96.09%
CHEMBL253 P34972 Cannabinoid CB2 receptor 89.46% 97.25%
CHEMBL4203 Q9HAZ1 Dual specificity protein kinase CLK4 87.90% 94.45%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 86.36% 95.56%
CHEMBL4227 P25090 Lipoxin A4 receptor 81.60% 100.00%
CHEMBL2007 P16234 Platelet-derived growth factor receptor alpha 81.58% 91.07%
CHEMBL5608 Q16288 NT-3 growth factor receptor 81.38% 95.89%

Cross-Links

Top
PubChem 220338
NPASS NPC283908
ChEMBL CHEMBL1410398
LOTUS LTS0206738
wikiData Q418035